2020
DOI: 10.1007/s11897-020-00452-4
|View full text |Cite
|
Sign up to set email alerts
|

Iatrogenic Decompensated Heart Failure

Abstract: Purpose of Review To provide an overview of the potential iatrogenic causes of acute decompensated heart failure (AHF) and an evidence-based management strategy to address this. Recent Findings As the heart failure (HF) population continues to age and become burdened with greater comorbidities and polypharmacy, patients become more susceptible to the iatrogenic precipitants of HF. The following clinical scenarios are familiar to clinicians, but the sequelae to AHF are often unanticipated: HF medications withdr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(12 citation statements)
references
References 62 publications
0
12
0
Order By: Relevance
“…Adverse drug reactions (ADRs) have been estimated to account for approximatively 10–20% of hospital admissions in geriatric units [ 186 ]. Moreover, an observational study performed in 1996 highlighted that the iatrogenic problems accounted for nearly 7% of HF admissions and were associated with higher mortality and prolonged hospital stays compared with those of non-iatrogenic causes [ 187 , 188 ]. Thus, the decompensation of HF patients due to iatrogenic conditions is a well-known and documented problem, which leads to increased morbidity and mortality rates.…”
Section: Adverse Drug Reactions In Hf Patientsmentioning
confidence: 99%
See 1 more Smart Citation
“…Adverse drug reactions (ADRs) have been estimated to account for approximatively 10–20% of hospital admissions in geriatric units [ 186 ]. Moreover, an observational study performed in 1996 highlighted that the iatrogenic problems accounted for nearly 7% of HF admissions and were associated with higher mortality and prolonged hospital stays compared with those of non-iatrogenic causes [ 187 , 188 ]. Thus, the decompensation of HF patients due to iatrogenic conditions is a well-known and documented problem, which leads to increased morbidity and mortality rates.…”
Section: Adverse Drug Reactions In Hf Patientsmentioning
confidence: 99%
“…Several articles also discuss the negative outcomes of HF patients after discontinuing chronic HF treatment [ 2 , 187 , 198 , 199 , 200 ].…”
Section: Discontinuation Of Drugs In Hf Patientsmentioning
confidence: 99%
“…The European Society of Cardiology (ESC) recommends an oral anticoagulant to prevent thromboembolism for all patients with paroxysmal or persistent/permanent AF and a CHA2DS2-VASc score ≥2 (men) or ≥3 (women), irrespective of whether a rate or Therapeutic management. This figure was developed using expert consensus, guidelines and recommendations [9,16,24,[29][30][31][32][33] and specific studies [34][35][36][37][38][39][40][41][42][43][44][45][46][47].…”
Section: Thromboembolismmentioning
confidence: 99%
“…If haemoglobin is <8 g/dL, provide a transfusion, and if between 8 and 10 g/dL, discuss providing a transfusion. Anaemia and ID are independent risk factors for adverse outcomes in CHF and acute decompensated HF [41] with anaemia being an independent predictor of mortality [42].…”
Section: Anaemia and Iron Deficiencymentioning
confidence: 99%
See 1 more Smart Citation